Dana Philpott
Dana Philpott is a Professor and Associate Chair, Research, in the Department of Immunology at the University of Toronto. She is also the Academic Director for the gnotobiotic mouse facility at the Temerty Faculty of Medicine, which is the first of its kind in Toronto to offer germ-free and defined-community gnotobiotic mice. Dr. Philpott’s research employs animal models of inflammatory bowel disease (IBD) and considers how innate immunity and the microbiome shape immune homeostasis within the intestine. Dr. Philpott’s work aims to define new disease mechanisms and potential targets for therapy for these increasingly prevalent intestinal disorders.
Abstracts this author is presenting:
